4//SEC Filing
Hallam Trevor 4
Accession 0001209191-22-016854
CIK 0001382101other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 7:22 PM ET
Size
13.9 KB
Accession
0001209191-22-016854
Insider Transaction Report
Form 4
Hallam Trevor
Chief Science Officer
Transactions
- Exercise/Conversion
Common Stock
2022-03-05+12,500→ 82,095 total - Tax Payment
Common Stock
2022-03-05$8.17/sh−4,278$34,951→ 77,817 total - Award
Stock Option (right to buy Common Stock)
2022-03-04+52,000→ 52,000 totalExercise: $8.17Exp: 2032-03-03→ Common Stock (52,000 underlying) - Award
Restricted Stock Unit (RSU)
2022-03-04+39,000→ 39,000 totalExp: 2026-03-04→ Common Stock (39,000 underlying) - Exercise/Conversion
Restricted Stock Unit (RSU)
2022-03-05−12,500→ 37,500 totalExp: 2025-03-05→ Common Stock (12,500 underlying)
Footnotes (5)
- [F1]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F2]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person.
- [F3]The option vests as to 2.0833% of the total shares monthly, beginning on April 4, 2022, with 100% of the total shares vested and exercisable on March 4, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.
- [F4]The RSUs vest as to 1/4th of the total shares annually beginning on March 4, 2023, subject to continued service through each vesting date.
- [F5]The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date.
Documents
Issuer
SUTRO BIOPHARMA, INC.
CIK 0001382101
Entity typeother
Related Parties
1- filerCIK 0001326592
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 7:22 PM ET
- Size
- 13.9 KB